ReviewCancers2021

Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer.

Cheng-Hao Chuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.